BG107356A - 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав - Google Patents

5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав Download PDF

Info

Publication number
BG107356A
BG107356A BG107356A BG10735602A BG107356A BG 107356 A BG107356 A BG 107356A BG 107356 A BG107356 A BG 107356A BG 10735602 A BG10735602 A BG 10735602A BG 107356 A BG107356 A BG 107356A
Authority
BG
Bulgaria
Prior art keywords
hydroiodide
thiazolidine
ethoxy
benzyl
amino
Prior art date
Application number
BG107356A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Craig
Tim HO
Michael Millan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG107356A publication Critical patent/BG107356A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG107356A 2000-06-08 2002-12-05 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав BG107356A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014005.3A GB0014005D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002545 WO2001094343A1 (en) 2000-06-08 2001-06-08 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical

Publications (1)

Publication Number Publication Date
BG107356A true BG107356A (bg) 2003-06-30

Family

ID=9893256

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107356A BG107356A (bg) 2000-06-08 2002-12-05 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав

Country Status (26)

Country Link
US (1) US20040024027A1 (de)
EP (1) EP1292595A1 (de)
JP (1) JP2003535861A (de)
KR (1) KR20030007919A (de)
CN (1) CN1443185A (de)
AP (1) AP2002002684A0 (de)
AU (2) AU6255001A (de)
BG (1) BG107356A (de)
BR (1) BR0111508A (de)
CA (1) CA2411064A1 (de)
CZ (1) CZ20024029A3 (de)
DZ (1) DZ3383A1 (de)
EA (1) EA004298B1 (de)
GB (1) GB0014005D0 (de)
HU (1) HUP0301799A3 (de)
IL (1) IL153280A0 (de)
MA (1) MA26912A1 (de)
MX (1) MXPA02012173A (de)
NO (1) NO20025882L (de)
NZ (1) NZ522997A (de)
OA (1) OA12283A (de)
PL (1) PL363683A1 (de)
SK (1) SK17152002A3 (de)
WO (1) WO2001094343A1 (de)
YU (1) YU93002A (de)
ZA (1) ZA200300017B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (de) * 1987-09-04 1998-05-20 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
DZ3383A1 (fr) 2001-12-13
OA12283A (en) 2003-11-10
WO2001094343A1 (en) 2001-12-13
HUP0301799A3 (en) 2005-04-28
YU93002A (sh) 2006-01-16
AU2001262550B2 (en) 2004-04-22
EP1292595A1 (de) 2003-03-19
JP2003535861A (ja) 2003-12-02
CN1443185A (zh) 2003-09-17
BR0111508A (pt) 2003-03-25
AU6255001A (en) 2001-12-17
PL363683A1 (en) 2004-11-29
US20040024027A1 (en) 2004-02-05
NO20025882D0 (no) 2002-12-06
CA2411064A1 (en) 2001-12-13
CZ20024029A3 (cs) 2003-04-16
EA200300004A1 (ru) 2003-04-24
NZ522997A (en) 2004-05-28
EA004298B1 (ru) 2004-02-26
SK17152002A3 (sk) 2003-05-02
NO20025882L (no) 2003-01-29
ZA200300017B (en) 2004-04-08
AP2002002684A0 (en) 2002-12-31
MXPA02012173A (es) 2003-04-25
KR20030007919A (ko) 2003-01-23
IL153280A0 (en) 2003-07-06
HUP0301799A2 (hu) 2003-12-29
MA26912A1 (fr) 2004-12-20
GB0014005D0 (en) 2000-08-02

Similar Documents

Publication Publication Date Title
HRP20000404A2 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
KR20020028873A (ko) 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
EA004541B1 (ru) Полиморф 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона, соли малеиновой кислоты
HRP20000408A2 (en) 5-(4-(2-(n-metyl-n-(2-pyridyl)amino)ethoxy(benzyl(thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
HRP20000405A2 (en) Hydrate of 5-/4-/2-(n-methyl-n-(2-pyridil)amino) ethoxy)benzyl/thiazolidine-2,4-dione, maleic acid salt
EP1305312B1 (de) Tartratsalze eines thiazolidinedione derivats
BG107356A (bg) 5-(4-(2-(n-метил-n-(2-пиридил)амино)етокси)бензил)тиазолидин-2,4-дион хидройодид като фармацевтиченсъстав
EA004769B1 (ru) Новый фармацевтический препарат
BG107357A (bg) Тиазолидиндионова сол за лечение hа захарен диабеt
KR100917953B1 (ko) 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온의 나트륨염
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
EA005408B1 (ru) Тартратная соль производного тиазолидиндиона
EP1305310B1 (de) Tartratsalze eines thiazolidinedione derivats
BG107678A (bg) Тиазолидиндионово производно и използването му като антидиабетично средство
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative